---
title: "Kanhoo's major shareholder, Wang Guojiang, plans to reduce his holdings by no more than 1%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260478157.md"
description: "According to the Zhitong Finance APP, Kanhoo announced that Mr. Wang Guojiang, a shareholder holding more than 5%, plans to reduce his holdings of the company's shares by no more than 2.7589 million shares (approximately 1% of the company's total share capital) through centralized bidding within three months after the disclosure of this reduction plan"
datetime: "2025-10-09T13:56:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260478157.md)
  - [en](https://longbridge.com/en/news/260478157.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260478157.md)
generator: "portal-rs"
---

# Kanhoo's major shareholder, Wang Guojiang, plans to reduce his holdings by no more than 1%

According to the Zhitong Finance APP, Kanhoo (300340.SZ) announced that Mr. Wang Guojiang, a shareholder holding more than 5% of the shares, plans to reduce his holdings of the company's shares by no more than 2.7589 million shares (approximately 1% of the company's total share capital) through centralized bidding within three months after the disclosure of this reduction plan, starting from fifteen trading days thereafter

### Related Stocks

- [300340.CN](https://longbridge.com/en/quote/300340.CN.md)

## Related News & Research

- [MINEST: Record-breaking production and improved financials support global tidal energy expansion](https://longbridge.com/en/news/296446821.md)
- [12:25 ETAce Pickleball Club Media Launches Beyond The Bounce Digital Magazine and Opens Investment Opportunity to the Public](https://longbridge.com/en/news/296638710.md)
- [Petronas Chemicals reports higher revenue and profit but flags challenging outlook for the year](https://longbridge.com/en/news/296307726.md)
- [SpareBank 1 Østlandet employee share buyback offer book closes Aug. 20 at 16:00 CEST](https://longbridge.com/en/news/296449504.md)
- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**